Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$191.51 - $216.16 $81,391 - $91,868
-425 Reduced 27.31%
1,131 $240,000
Q2 2023

Jul 17, 2023

BUY
$187.64 - $206.25 $291,967 - $320,925
1,556 New
1,556 $298,000
Q1 2021

Apr 27, 2021

SELL
$137.51 - $190.8 $185,500 - $257,389
-1,349 Closed
0 $0
Q4 2020

Jan 26, 2021

BUY
$164.63 - $211.93 $222,085 - $285,893
1,349 New
1,349 $760,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.